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ABSTRACT 
Objective: The aims of the study to enhance solubility and dissolution of famotidine using natural polymer. Solubility study of a drug is one of the 
contributing factors of its oral bioavailability. The formulation of poorly soluble drugs for oral delivery presents a challenge to the formulatio n 
technologists. 
Methods: The present study has shown that it is possible to raise the solubility for poorly soluble drugs like famotidine, by preparing solid 
dispersion using natural water-soluble polymer (xyloglucan and hyaluronic acid) as solubilizer through solvent evaporation method. Physical 
mixture and solid dispersion of famotidine with xyloglucan (XG) or hyaluronic acid in a ratio of 1:1, 1:2, 1:3 were prepared. Solubility study, drug 
content, dissolution profile and compatibility study were performed for famotidine in solid dispersions XS1, XS2, XS3, HS4, HS5, HS6 as well as in 
physical mixtures at a ratio 1:1 for both polymer (XG and hyaluronic acid). 
Results: It was observed that solid dispersions of each drugs showed an increase in dissolution rate in comparison with its pure drug in the ratio of 
1:1 (Drug: carrier). It can be concluded that with the care and proper use of xyloglucan, the solubility of drugs poorly soluble can be improved. 
The prepared solid dispersion showed improvement of drug solubility in all prepared formulas. The best result was obtained with formula XS1 
(famotidine: xyloglucan at ratio 1:1) that showed 26 fold increase in solubility compared to the solubility of pure drug. 
Conclusion: The natural solid dispersion, increased wettability and reduced crystallinity of the drug which leads to improving solubility and dissolution. 
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INTRODUCTION 
Therapeutic efficacy of a drug-related to the bioavailability and finally 
upon the solubility of drug particles. Solubility performance of a drug 
substance is one of the key factors of its oral bioavailability. In current 
years, the list of drug poorly soluble applicants has increased hugely. 
The poorly soluble drugs formulation for oral transport presents an 
experiment to the formulation researchers. The rate and extent of 
absorption the drug from any dosage form depend on the rate and 
extent of dissolution of the active ingredient [1]. 
The various method responsible for increase solubility and the 
dissolution rate of poorly soluble drugs such as liquisolid, in which 
inert carrier’s molecules is loaded with drug particles [1]. Increase 
wettability and solubility of the hydrophobic drug by numerous 
surfactants at different charges [2]. Another method i.e. drug 
micronization is inappropriate method because after micronization 
the product has been agglomerated. The solid dispersion by natural 
polymer is also one of the procedure to formulate solid dispersions 
because of its simplicity of preparation, more effective, not require 
instruments more expensive and ease of optimization [3]. In solid 
dispersion method, whereby the active drug were dispersed in 
natural polymer, typically with a view to enhancing solubility, 
dissolution rate and oral bioavailability [4]. 
Xyloglucan (XG) is a biodegradable polysaccharide extracted from 
Tamarind seeds has been found to have an extensive application in 
the pharmaceutical industry [5]. However, hyaluronic acid a 
naturally polymer, besides being biodegradable, showed to be highly 
biocompatible [6]. 
Famotidine is classified into Class II based on Biopharmaceutics 
Classification System, having a low solubility and high permeability.  
Strongly act on H2 receptors, reduced acid secretion and it protect 
mucosal acid secretions for 10-12 h then metabolized and 
elimination by renal route. Famotidine freely soluble in glacial acetic 
acid [7]. Famotidine also decrease both basal, food-stimulated acid 
secretion by 90% as well as promotes healing of duodenal ulcer [8]. 
With Molecular Formula: C8H15N7O2S3 and Its structural formula 
is shown in fig. 1: 
 
 
Fig. 1: Chemical structure of famotidine 
 
This drug is BCS class II drug having low solubility. Therefore, it 
needs to formulate into its novel form for solubility enhancement 
[9]. In this study, novel solid dispersion was prepared using XG or 
hyaluronic acid as hydrophilic natural carrier. The dissolution of 
drug from natural solid dispersion formulation were examined in 
phosphate buffer pH 4.5. The aim this work was to design, prepare 
and evaluate natural solid dispersions of famotidine with XG or 
hyaluronic acid using solvent evaporation method for solubility 
enhancement of famotidine. 
MATERIALS AND METHODS 
Material 
Xyloglucan and hyaluronic acid was purchased from Hyperchem(China). 
Potassium dihydrogen phosphate was purchased from Thomas Baker, 
India. Famotidine was provided by (Samarra Drug Industry, Iraq). 
Substance and reagent used were all of analytical grade. 
Characterization of famotidine 
Melting point 
Determining the melting point of famotidine was according to the 
method stated by the USP. First, a glass capillary tube charged, one 
end of which is sealed, with a enough amount of dry powder to form 
a column in the bottom of tube 2.5 to 3.5 mm high when packed 
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down as closely as possible by enough tapping on a solid surface. 
Then these packed capillary tubes placed in electrical melting point 
apparatus and start heating with monitoring until complete melting 
of powder [10]. 
Determination of λ max 
Twenty milligrams of famotidine were dispersed in 100 ml 0.1N 
phosphate buffer pH 4.5(prepared by dissolving 13.6 g. of 
monobasic potassium phosphate in 1L distilled water) [10] to 
prepare 0.2 mg/ml stock solution. From this stock solution, a dilute 
solution (20μg/ml) was prepared and scanned by UV 
spectrophotometer at the range of 200-400 nm to obtain the λ max 
of famotidine in this media. 
Same procedure was used for the determination of λ max of 
famotidine in water, by using water as a solvent instead of 0.1N 
phosphate buffer pH 4.5 
Preparation of calibration curves 
Calibration curves of famotidine in 0.1N phosphate buffer (pH 4.5) 
and distilled water were constructed by preparing serial dilutions of 
the drug from 0.2 mg/ml stock solution for each medium. The 
prepared samples were analyzed spectrophotometrically for 
famotidine at its λ max in both mediums. The determined 
absorbance values were plotted versus the concentration. 
Determination of saturated solubility in water 
Saturation solubility studies were carried out using distilled water 
as a solvent using theshake–flask method. Excess amount of 
famotidine pure powder was taken and added to water (10 ml) with 
continuous shaking for 48 h at 25 °C. The sample was then taken and 
filtered by using Millipore filter paper 0.45 μm. The filtrate was 
suitably diluted with distilled water and analyzed at the specified 
λmax to determine the dissolved quantity of famotidine [11]. 
Methods 
Preparation of physical mixture 
Physical mixture (PM) of famotidine with natural polymer (XG or 
hyaluronic acid) was prepared at ratio of 1:1 (w/w) as shown in 
table 1. The mixture was mixed homogeneously, stored in a sealed 
container and kept in a desiccators [12]. 
Preparation of solid dispersion 
Natural solid dispersions of famotidine were prepared by solvent 
evaporation method using natural polymers like XG and hyaluronic 
acid as carriers in 1 : 1, 1: 2 and 1: 3 ratios as shown in table 1. 
Famotidine was dissolved in glacial acetic acid to get clear solution. 
XG or hyaluronic acid were dispersed as fine particles and the 
solvent was removed by evaporation at room temperature. The 
dried mass was stored in desiccator until constant mass was 
obtained, crushed, and passed through sieve no. 22 [12, 13]. 
 
Table 1: Composition of solid dispersion 
Formula code Polymer Drug: polymer 
ratio 









Characterization of solid dispersion and physical mixture 
Calculation of percentage yield 
The percentage yields were calculated to determine the efficiency of 
the methods which were used for the preparation of binary systems 
and it helps in the choice of appropriate method of production. The 
prepared natural solid dispersion were weighed after drying, and 
percentage yield was calculated as in the following equation [14]. 
Percentage yield =
Actual weight of the prepared granules 
Weight of drug + polymer
× 100 
Drug content 
The powder equivalent to 20 mg famotidine was weighed and 
transferred to 100 ml volumetric flask and volume was made up to 
the mark with 0.1 N KH2PO4 buffer. From this 1 ml was taken in 10 
ml volumetric flask and the volume was adjusted up to the mark 
with buffer. After sufficient dilution with 0.1 N KH2PO4 buffer, 
samples were analyzed for famotidine spectrophotometrically at its 
λ max. Famotidine content was calculated by comparison the 
obtained absorbance with the calibration curve [15]. 
Saturation solubility test 
To evaluate the increase in solubility of famotidine in Solid 
dispersions XS1, XS2, XS3, HS4, HS5, HS6 as well as in Physical 
mixtures PM1, PM2. Excess of formulations were added to 10 ml of 
distilled water taken in a stoppered conical flasks were shaken for 
48 h at 25 °C in incubator shaker. after shaking to achieve 
equilibrium, 5 ml aliquots were withdrawn and filtered through 
using millipore filter paper 0.45 μm. The filtrate was analysed  
spectrophotometrically [16] at λmax. 280 nm. Readings were taken 
in triplicate and observations are recorded. 
Selection of the best formula 
The best natural solid dispersion formula is to be selected depending 
on the results of percentage yield and solubility and subjected for 
further studies. 
In vitro dissolution study 
An amount equivalent to 20 mg of pure drug, accepted solid 
dispersion or its corresponding physical mixture was placed in 
dissolution apparatus type II (Paddle) at the rotation speed of 50 
rpm using 900 ml 0f 0.1 N PH 4.5 KH2PO4 buffer as dissolution 
media at 37±0.5 °C. After fixed time intervals 5 ml of sample was 
withdrawn and replaced by equal volume of fresh medium, to 
maintain sink condition. These samples were analyzed using UV-
Visible Spectrophotometer at famotidine λmax [10]. 
Compatibility study 
Differential scanning calorimetry (DSC) 
Thermal properties of the pure drug, selected formula (XS1) and its 
corresponding physical mixture (PM1) were analyzed by DSC using 
aluminum pan with about 2 mg of the above samples. 
The samples were heated in a hermetically sealed aluminum pan. 
Heat runs for each sample were set from 25 °C to 300 °C under 
dynamic N2 atmosphere and heating rate of 10 °C/min [17]. 
Statistical analysis 
The results of the research were given as mean values±standard 
deviation (SD) and examined according to the one-way analysis of 
variance (ANOVA) at which significant results (p<0.05) and non-
significant (p>0.05). 
RESULTS AND DISCUSSION 
Characterization of famotidine 
Determination of melting point 
The melting point of famotidine was found to be 164 °C. This result 
was within the reported range which is 163 to 164 °C[18]. This 
indicates the purity of drug powder. 
Determination of λ max 
The wave lengths of maximum absorbance (λ max) for famotidine in 
0.1N phosphate buffer pH 4.5 and in distilled water were 266 nm 
and 280 nm respectively as shown in fig. 2 and fig. 3 respectively 
which were in agreement with the reported results [18, 19]. 
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Fig. 2: UV spectrum of famotidine in phosphate buffer (pH 4.5) 
 
 
Fig. 3: UV spectrum of famotidine in distilled water 
 
 
Fig. 4: Calibration curve of famotidine in 0.1M phosphate buffer (pH 4.5) 
 
 
Fig. 5: Calibration curve of famotidine in distilled water 
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Calibration curve of famotidine in 0.1N phosphate buffer pH 4.5 
and distilled water  
Calibration curves of famotidine in 0.1N phosphate buffer pH 4.5 
and distilled water are represented in fig. 4 and fig. 5. The curves 
were linear at the concentration range of 5-20 μg/ml with 
regression values of 0.9959 and 0.9977 respectively. The high 
regression values indicate that the calibration curves follow 
Beer’s law. 
Determination of saturated solubility in water 
The saturated solubility of famotidine in water was found to be 
equal to 0.405 mcg/ml, This indicated that the drug is very slightly 
soluble in water as mentioned in BP [20]. 
Characterization of melt granules and physical mixture 
Percentage yield 
The percentage yield of the prepared natural solid dispersion and 
physical mixture is shown in table 2. High percentage yield was 
obtained in the case of drug: polymer ratio of 1:1 in comparison to a 
ratio of 1:2 and 1:3 due to less stickiness of the resulted mass with 
ease penetration through the sieve. 
Drug content 
The percentage of drug content of the prepared natural solid 
dispersion and physical mixture is shown in table 2. All formulations 
had drug content values within the range of 88.7–100%. 
Solubility  
The saturation solubility of pure drug, prepared natural solid 
dispersion and physical mixture is shown in table 2. The solubility of 
prepared solid dispersion was improved compared to pure drug 
powder and physical mixtures. The improvement insolubility of the 
solid dispersion can be explained to be due to the hydrophilic nature 
of the used polymers that adsorbed on drug surface [21] and 
improve its wettability, so the solubility was improved [22]. 
Selection of the formula  
Depending on the solubility and Percentage yield results, xyloglucan 
at ratio 1:1 was the best polymer for enhancing the solubility of 
famotidine. So XS1 is the best-selected formula for further studies. 
In vitro dissolution studies 
The in vitro dissolution profiles of the pure drug, XS1 and its 
corresponding physical mixture in phosphate buffer pH 4.5 for 30 
min are shown in fig. 6. The dissolution of pure drug was rather 
slow. Since, the cumulative amount of dissolved drug after 5 min. 
was about 24%, while XS1 formulation showed the greatest amount 
of drug release, about 80.7 % within 5 min.  
The dissolution rate of the physical mixture was improved as 
compared with pure drug, but to a lesser extent than that of the solid 
dispersion, this might be due to the surface tension lowering effect 
of polymer to the medium, resulting in wetting of hydrophobic drug 
of crystalline surface [23]. The fastest dissolution of XS1 is due to its 
dispersion in the hydrophilic polymer (XG). 
 
Table 2: Percentage yield, drug content and solubility of the prepared solid dispersion 








Pure drug --------- 1:0 100±0.00 100±0.00 0.405±0.002 
XS1  
XG 
1:1 97.7±1.53 98±0.00 10.436±0.045 
XS2 1:2 91.3±1.15 91±1.00 6.368±0.326 
XS3 1:3 98.7±0.58 94.6±1.52 4.487±0.251 
PM1 1:1 100±0.00 99.7±0.58 1.073±0.011 
HS4  
Hyaluronic acid 
1:1 95.7±0.58 78.3±2.08 1.276±0.009 
HS5 1:2 88±1.00 87±1.00 1.187±0.012 
HS6 1:3 91±0.00 90.7±0.58 0.882±0.017 
PM2 1:1 100±0.00 99±1.00 0.931±0.010 
*mean±standard deviation (SD), n=3 
 
 
Fig. 6: Drug release profiles of pure drug, melt granules and physical mixture 
 
Compatibility study 
Differential scanning calorimetry (DSC) 
The DSC thermograms of famotidine, xyloglucan, physical mixture and 
nature solid dispersion (XS1) are illustrated in (fig. 7 A through D). 
Pure drug and polymer showed sharp endothermic peak at 162.21 °C 
and 176.47 °C respectively [24] which were attributed to their melting 
points indicating the purity and the crystalline nature of each. Physical 
mixture showed peaks for both components at nearly the same 
melting point for each indicating no interaction between them. In 
addition, the thermogram for the selected granules also showed the 
sharp endothermic peaks with no great change in the melting point of 
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each component, indicating that, the crystalline nature was preserved 
during the granulation process. This result was in agreement with that 
with previous results. So it may be concluded, that the increase in 
solubility of the drug was mainly due to wetting of drug by its 
dispersion in the hydrophilic polymer (xyloglucan) rather than its 
conversion from crystalline form to amorphous form [25]. 
 
 
Fig. 7: DSC Thermograms of (A) famotidine, (B) xyloglucan(C) physical mixture,(D) natural solid dispersion 
 
CONCLUSION 
Depending on the obtained result of this study, solid dispersion has been 
proved to be a viable process to enhance solubility and dissolution rate 
of famotidine, using a hydrophilic natural polymer as nature polymer 
xyloglucan. Nature polymers like xyloglucan and hyaluronic acid were 
found to have a positive effect on solubility. The drug: polymer ratio, in 
addition to polymer type, affect the solubility of the drug. The optimum 
ratio of drug: xyloglucan was (1:1) with doubling in saturated solubility 
of the drug. Analysis by DSC of granules of selected formula indicated the 
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